Year-over-year earnings per share growth for the last twelve months: QuidelOrtho (QDEL)

QuidelOrtho (QDEL) - corporate logo

The launch of the Savanna system and the synergy effects from the merger amid growth in core testing served as the primary drivers for QuidelOrtho (QDEL). This quarterly EPS chart illustrates the market response, where the current status is 92.30. Stability is underpinned by automated cleanroom lines and a global network of manufacturing plants across Europe and the US, which strictly adhere to temperature controls to ensure the uninterrupted supply of reagents.

Quidel Corporation (QDEL) Net earnings per share growth for the trailing year: for the period 07/04/2022 - 11/13/2026
Flagship merchandise of QuidelOrtho Inc.

The market evaluates QuidelOrtho (QDEL) through the lens of its adaptation to post-pandemic demand. This indicator captures the growth rate of net earnings per share, measuring capital generation efficiency on a quarterly basis. By analyzing changes in quarterly EPS dynamics, investors can discern the actual speed of business scaling. For QuidelOrtho (QDEL), this trend is smoothed by stable revenue from consumables for installed analyzers. This positive trajectory confirms the fundamental resilience of the model.

Analysis of competing companies

A: Quarterly EPS earnings growth|DGX - Year-over-year net earnings per share change for the last twelve months|Year-over-year earnings per share growth for the last twelve months Illumina Corp|Exact Sciences Inc. (EXAS) - Year-over-year net earnings per share change for the last twelve months|Year-over-year earnings per share growth for the last twelve months Revvity, Inc. (RVTY)|bio-rad.com (BIO) - Net earnings per share growth for the trailing year|Anbio - Year-over-year net earnings per share growth for the last 12 months|Quarterly EPS earnings growth Sotera Health Corp SHC|OPKO Corp - Quarterly EPS earnings growth|Year-over-year net earnings per share change for the last twelve months CareDx, Inc CDNA|MRVI: Quarterly EPS earnings growth|Year-over-year earnings per share growth for the last 12 months FLGT|LAB (Standard BioTools) - Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months Cytek Biosciences Inc CTKB|Year-over-year earnings per share growth for the last twelve months OraSure Technologies Inc (OSUR)|Year-over-year earnings per share growth for the last twelve months XGN (exagen.com)|Year-over-year earnings per share growth for the last twelve months MDxHealth SA MDXH|luciddx.com (LUCD) - Earnings per share growth in annualized terms for the last twelve months|PRE - Year-over-year earnings per share growth for the last twelve months|Year-over-year earnings per one share growth for the last 12 months IMDX (Insight Molecular Diagnostics)|TRIB (trinitybiotech.com) - Year-over-year net earnings per share growth for the last 12 months|PRPH: Year-over-year earnings per share growth rate for the last twelve months|AIMD (Ainos, Inc.) - Quarterly EPS earnings growth|CODX: Year-over-year earnings per one share growth for the last 12 months|Year-over-year earnings per share growth for the last twelve months HeartSciences (HSCS)|BMRA - Earnings per share growth in annualized terms for the last twelve months|Year-over-year earnings per share growth for the last twelve months Cardio Diagnostics Holdings CDIO|Net earnings per share growth for the trailing year Onconetix Corporation|Virax Biolabs Group - Quarterly EPS earnings growth|BJDX (bluejaydx.com) - Year-over-year earnings per share growth for the last 12 months|AWH: Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months Accelerate Diagnostics Inc. (AXDX)|Year-over-year earnings per share growth for the last twelve months CENTOGENE|Year-over-year earnings per share growth for the last twelve months ENZ|Year-over-year earnings per share growth for the last twelve months Fresh2 Group Limited (FRES)|Year-over-year net earnings per share growth for the last 12 months gtglabs.com GENE|Quarterly EPS earnings growth ME (23andMe)|Psychemedics Corp. (PMD) - Earnings per share growth in annualized terms for the last twelve months